SenzaGen's chairman Carl Borrebaeck has received the Biotech Builders Award 2017
SenzaGen's chairman, Professor Carl Borrebaeck, has received the prestigious BiotechBuilders Award for his ground-breaking medical research and prominent role as entrepreneur in Life Science, including being the co-founder of SenzaGen, Immunovia, Alligator Bioscience and BioInvent. The award was announced at the annual BiotechBuilder's meeting in Stockholm on 28 August. Through his involvement in SenzaGen, Carl Borrebaeck has contributed to the development of GARD™ - a gene-based test that evaluates the allergenic properties of chemical substances, thus eliminating the need for animal testing.